Trial intelligence / Profile preview

Local DHEA versus estradiol for dyspareunia due to vulvovaginal atrophy in postmenopausal women

2020-003254-76Phase 4Active

Sponsor
Karolinska University Hospital
Start
Jul 2020
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in vaginal atrophy comparing Local prasterone (DHEA) with Local estradiol (2 arms). Primary endpoint: Dyspareunia improvement at week 12. Started Jul 2020; status: active.

02

Drugs

dehydroepiandrosteroneestradiol
03

Conditions

vaginal atrophy

Beyond the preview

Go deeper on 2020-003254-76.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-003254-76.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call